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Abstract: 
 
Donor human milk is critical for the fragile preterm infant who does not have access to his or her 
mother’s milk, improving survival rates and quality of survival and decreasing hospital stay. 
Despite the opening of donor milk banks around the world, shortages continue as demand for 
donor milk exceeds supply. One potential means of increasing supply is by reducing exclusion 
criteria that prohibit mothers from donating milk based on duration of lactation. Minimal 
research has been done on the composition of human milk during the second year of lactation, 
with most research focusing on the nutritive compounds and not the immunoprotective 
compounds. Several immunoprotective compounds, including lysozyme, lactoferrin, secretory 
immunoglobulin A, and oligosaccharides, are abundant in human milk compared to bovine-
based infant formula and are partially or fully retained during Holder pasteurization, making 
them an important differentiating feature of donor milk. A PubMed search was conducted to 
review studies in human milk composition during the second year of lactation. Limitations of 
existing research include sample collection protocols, small study sizes, and use of populations 
that may have been at risk for nutritional deficiencies. Stable concentrations of several 
components were reported including protein, lactose, iron, copper, lactoferrin, and secretory 
immunoglobulin A. Lysozyme concentration increased during extended lactation, while zinc and 
calcium concentrations declined into the second year. Conflicting findings were reported on fat 
content, and no information was available regarding oligosaccharide content. More research is 
needed to create evidence-based guidelines regarding the nutritive and immunoprotective value 
of donor milk throughout the course of lactation. 
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Article: 
 
Background 
 
Human milk is not only a source of essential nutrients for the developing infant; it also provides 
numerous bioactive factors that enhance the immune response and stimulate development of the 
immature gastrointestinal (GI) tract, providing a variety of well-documented health benefits to 
the infant.1-3 Multiple studies have shown that human milk is especially important for the fragile 
preterm infant, with those receiving human milk less likely to develop necrotizing enterocolitis 
(NEC), a potentially life-threatening condition, compared to those receiving infant formula.4-6 A 
systematic review of the use of donor milk with preterm infants showed that donor milk was 
associated with a lower risk of NEC compared to infant formula.7 Human milk promotes 
development of the GI tract by quickly reducing intestinal permeability,8 induces lactase 
activity,9 and contains multiple factors to stimulate growth, motility, and maturation of the 
intestine.10 Premature infants fed human milk have reduced incidence of sepsis11-13 and other 
infections.14 Human milk is also used in the treatment of metabolic disorders,15 chronic renal 
failure,16 and failure to thrive.17 
 
The recipients with the greatest need for donor milk are very low birth weight (VLBW) infants 
whose mothers cannot produce milk or may have a delay in producing sufficient milk due to 
illness or death, use of medications, or poor breastfeeding support.18 Therefore, these infants 
must rely on donor milk, which is collected, processed, and distributed by a human milk bank, if 
they are to receive human milk. 
 
Recent years have seen the opening of new milk banks around the world to keep up with 
growing demand for this critical product, with new banks added in countries as diverse as 
Canada, Cape Verde, India, and Australia.19-22 Despite the increasing number of human milk 
banks, shortages continue to be reported, primarily in the United States, due to growing 
demand.23,24 
 
Table 1. Examples of Lactation-Duration Exclusions by Milk Bank or Milk Bank Networka 
Milk Bank or Milk Bank Network Lactation-Duration-Based Exclusion 
PREM Bank (Western Australia)29 “We do not accept new donor mothers to the milk bank who have 
started their babies on solids or are still breastfeeding their 
babies after 12 months of age.” 
Brazil (government run)30 No lactation-duration exclusion 
French Human Milk Bank Association (ADLF)31 No lactation-duration exclusion 
Associazione Italiana Banche del Latte Umano 
Donato (AIBLUD)32 
Must begin donating before infant is 6 months old; no 
information on how long donation can continue 
Milk Matters (Cape Town, South Africa)33 No lactation-duration exclusion 
United Kingdom Association for Milk Banking34 Usually must begin donating before infant is 6 months old and 
“continue for as long as they wish” 
Human Milk Bank Association of North America 
(HMBANA)73-78 
Practices vary with many milk banks excluding donors beyond 1 
year 
a Based on information on milk bank websites. 
 
Brazil is considered a global leader in donor milk banking. To compare the theoretical capacity 
of Brazil’s donor milk banking system to the theoretical capacity in North America, we 
compared the volume of donor milk collected to the number of preterm births.25-28 In 2011, 
Brazil collected 593 mL of donor milk per preterm birth (165 702 L total) compared to 125 mL 
per preterm birth in North America (64 557 L total). One factor that may be contributing to this 
difference in volume is varying practices regarding the acceptance of donor milk from mothers 
who have been lactating for more than 1 year (extended lactation). We contacted all 13 milk 
banks in the Human Milk Banking Association of North America (HMBANA) network between 
November 2012 and March 2013 to ask if they accepted donors beyond 1 year and found that 8 
of the banks excluded mothers from donating once their baby turned 1 year old. Brazil does not 
have a similar lactation-duration-based exclusion, and policies and practices vary at milk banks 
around the world (Table 1).29-34 Informal observations of social media discussion boards indicate 
that extended-lactation mothers are interested in donating milk and are frustrated with being 
turned away from donor milk banks in North America. 
 
Limited research has been done on the compositional changes to human milk during extended 
lactation, which likely contributes to the variation in milk bank practices around the world, and 
most research has focused on the nutritional composition and not the immunoprotective 
compounds. Immunoprotective compounds that have been discovered in human milk include, 
but are not limited to, secretory immunoglobulin A (sIgA), lysozyme, lactoferrin, human milk 
oligosaccharides, growth factors, hormones such as prolactin and progesterone, enzymes such as 
amylase and lipase, cytokines, and fatty acids.35 Several bioactive compounds are present in 
significantly higher concentrations in human milk compared to bovine milk-based infant 
formulas,36,37 including lysozymes, lactoferrin, sIgA, and human milk oligosaccharides (HMOs) 
(Table 2). Lysozymes and lactoferrin are antimicrobial proteins that disrupt the cell wall of 
bacteria38; sIgA is an immunoglobulin protein customized to bind pathogens found in the 
mother’s (and thus the baby’s) environment39; and HMOs are short-chain, indigestible sugars 
that appear to have several functions in the development of the infant GI tract including pathogen 
binding, immune system development, and serving as a growth factor for bifidobacteria 
colonization.40,41 These bioactive compounds have been shown to have partial or complete 
retention after Holder pasteurization,42,43 making them important differentiating factors in the 
composition of pasteurized donor milk as an alternative to infant formula. 
 
Table 2. Select List of Bioactive Factors in Human Milk as Compared to Bovine Milk and Their 
Retention after Holder Pasteurization 
Bioactive Factor Role38-41 Concentration in Human Milk 
Compared to Bovine Milk36,37 
% Reduction after Holder 
Pasteurization42,43 
Lysozymes Antimicrobial protein 3000 times more in human milk No effect to 24%-60% 
reduction 
Lactoferrin Antimicrobial protein 75 times more in human milk 57%-80% reduction 
Secretory 
immunoglobulin A 
Antibody that protects epithelial 
tissue from pathogens 
5000 times more in human milk 0%-48% reduction 
Human milk 
oligosaccarides 
Serve as prebiotic for 
development of commensal gut 
microflora; pathogen 
Third most abundant ingredient (5-10 
g/L) in human milk compared to trace 
amounts in bovine milk 
No effect 
 
It is important to understand how human milk changes during extended lactation in order to 
create evidence-based recommendations regarding the potential nutritive and immunoprotective 
value of donor milk beyond 1 year of lactation. This review will summarize existing research on 
human milk composition beyond 1 year of lactation and will identify areas where additional 
research is needed. 
 
Method 
 
A PubMed search was conducted using the terms prolonged lactation, extended lactation, late 
lactation, and second year of lactation. Only studies that analyzed nutritive and select 
immunoprotective compounds in human milk based on duration of lactation that extended 
beyond 1 year postpartum were included in the review. The immunoprotective factors considered 
include lactoferrin, lysozyme, sIgA, and HMOs because these are abundant in human milk 
compared to infant formula and are known to be partially retained during pasteurization. 
Additional studies were located by reviewing the references of the initial studies. Studies were 
excluded if the sample size in the second year of lactation was smaller than 5,44 yielding a total 
of 12 studies45-56 that were conducted between 1970 and 2012 (Table 3). Ten of the studies 
measured nutritive compounds in milk (fats, lipids, carbohydrates, vitamins, and minerals), and 2 
studies looked at immunoprotective compounds. 
 
Table 3. Studies of Nutritive and Immunoprotective Compounds in Human Milk beyond 1 Year 
Study Design Size Duration Measurements General Notes 
Underwood et al, 
197045 
Longitudinal 133 6 weeks to 24 
months 
postpartum 
Protein, total fat, and fatty 
acid profile 
Study conducted among 
poor Pakistani mothers 
Lauber & Reinhardt, 
197946 
Cross-sectional 
and longitudinal 
33 1 month to 23 
months 
postpartum 
Protein, total fat, fatty acid 
profile, lactose, iron (Fe), 
zinc (Zn), copper (Cu), 
magnesium (Mg), vitamin C 
Study conducted among 
Ivory Coast mothers on a 
plant-based diet 
Vaughan et al, 197947 Semi-longitudinal 38 Up to 31 months 
postpartum 
Zn, Cu, Fe, calcium (Ca), Mg Mothers had good 
nutritional status 
Goldman et al, 198348 Cross-sectional 15 12 months to 24 
months 
postpartum 
Lactoferrin, lysozyme, 
secretory immunoglobulin 
A (sIgA) 
No additional information 
Dewey et al, 198449 Semi-longitudinal 46 1 month to 20 
months 
postpartum 
Protein, total fat, lactose, total 
energy, Ca, Zn, Fe, Cu, Mg, 
sodium (Na), potassium (K) 
Study conducted among 
mothers in the United 
States 
Prentice et al, 198450 Semi-longitudinal 152 Up to 26 months 
postpartum 
Lactoferrin, lysozyme, sIgA Gambian mothers received 
supplements to increase 
caloric intake 
Karra et al, 198651 Semi-longitudinal 40 7 months to 25 
months 
postpartum 
Zn, Ca, vitamin B6, vitamin 
C, folate 
Study conducted among 
mothers in United States 
with financial means for 
nutritionally adequate 
diet 
Bates & Tsuchiya, 
199052 
Semi-longitudinal 56 0 to 99 weeks 
postpartum 
Zn Gambian mothers received 
iron and riboflavin 
supplements 
Laskey et al, 199053 Cross-sectional 216 2 weeks to 26 
months 
postpartum 
Ca Gambian mothers had 
calcium-poor diet; 
mothers from UK had 
calcium-rich diet 
Mandel et al, 200554 Cross-sectional 61 2 months to 39 
months 
postpartum 
Total fat and total energy No additional information 
Shehadeh et al, 200655 Cross-sectional 84 3 months to > 1 
year postpartum 
Protein, total fat, fatty acid 
profile, lactose, Ca 
No additional information 
Lubetzky et al, 201256 Cross-sectional 55 2 months to > 1 
year postpartum 
Fatty acid profile No additional information 
 
Results 
 
Nutritive Changes 
 
Protein. Four studies45,46,49,55 were identified that examined total protein content in human milk 
beyond 1 year, and the picture that emerges is one of declining protein content during the first 6 
months of lactation, followed by stabilization at 1.0 to 1.2 g/dL, and then increased protein 
content during gradual weaning approaching 2 g/dL. This agrees with other studies that analyzed 
milk composition and the impact of weaning.57,58 A cross-sectional study55 found a 17% decline 
in total protein content from women lactating over 1 year (1.0 g/dL) compared to women 
lactating for 3 months (1.2 g/dL). A 2-year longitudinal study of Pakistani women45 reported 
similar declines in protein content from 6 weeks to 12 months postpartum, with protein values 
then increasing at 18 and 24 months postpartum. This late-lactation increase in protein was also 
associated with weaning in a semi-longitudinal study conducted in the United States of 46 
women from 7 months to 20 months postpartum.49 Under weaning conditions (milk volumes < 
300 mL/day), total protein increased to 2.0 g/dL, while in “full lactation” (milk volumes > 500 
mL/day), the protein content was stable between 7 and 20 months, at approximately 1.2 g/dL. 
Finally, a longitudinal study of mothers in rural Ivory Coast found a decline in protein content 
during the first 6 months of lactation and then concentrations stabilized at approximately 1.0 
g/dL.46 Garza et al looked at weaning effects in mothers who weaned prior to 1 year postpartum 
and observed similar elevations in protein content, suggesting that the protein content during 
weaning was similar to the protein content from the milk of women delivering preterm infants.57 
 
Total fat. Evaluating fat composition is historically difficult, given that the fat content of human 
milk changes both within a feeding cycle and diurnally.59 Five studies45,46,49,54,56 examined total 
fat content in human milk beyond the first year of lactation with equivocal results. One cross-
sectional study involving 61 mothers showed that the percentage fat content was significantly 
higher in women lactating for longer than 1 year (10.65% ± 5.07%) compared to those lactating 
between 2 and 6 months (7.36% ± 2.65%),54 while another cross-sectional study involving 84 
mothers showed no change in total fat between the milk of mothers nursing longer than 1 year 
(3.7 ± 1.9 g/dL) and those exclusively breastfeeding for 3 months (3.6 ± 1.6 g/dL).55 A 
longitudinal study conducted in the Ivory Coast through 23 months postpartum showed no 
change in total fat content in nonweaning mothers,46 while another longitudinal study conducted 
in Pakistan45 showed a trend toward increased lipid concentrations, with approximately 60% or 
more of the samples having a fat content greater than 3.3 g/dL after 18 months, compared to 
approximately 30% of the samples exceeding 3.3 g/dL at 6 months. This study also showed 
significant inter-individual variations in fat content. A semi-longitudinal study of 46 women in 
the United States concluded that fat content did not change between 4 and 20 months 
postpartum, though the study data actually showed a trend toward increased fat content in 
mothers producing greater than 500 mL of milk per day (3.45 g/dL + 1.53 at 7 to 11 months, 
compared to 4.84 g/dL + 1.19 at 12 to 20 months).49 Some of the observed study differences may 
be associated with differences in sample collection protocols.60 For example, some studies 
provided very specific instructions for sample collection (eg, collect from 1 breast 3 minutes 
after the start of lactation until the breast is completely emptied), while other studies provided 
more general instructions (eg, collect milk mid-lactation). No consistent observations have been 
made regarding whether there is a weaning effect on total fat concentrations.49,57,58 There is 
evidence based on 4 studies45,46,55,56 that the fatty acid profile of milk changes during the second 
year of lactation. One study measured a small but significant decline in long-chain fatty 
acids,55 and 3 studies showed a shift toward an increase in 14-carbon myristic acid.45,46,56 A 
possible explanation for this shift is that medium-chain fatty acids are synthesized by the 
mammary gland, while long-chain fatty acids come from dietary sources and may be reduced as 
mothers lose weight. 
 
Lactose. The lactose content of human milk during extended lactation was analyzed in 2 
studies46,49 and no significant changes were observed, with lactose concentrations remaining 
steady at approximately 7 g/dL. A third study reported total carbohydrate content in human milk 
and also found that this remained stable in the second year of lactation.55 Decreases in lactose 
content associated with gradual weaning have been observed when milk volumes fell below 300 
to 400 mL/day.49,58 
 
Zinc. It is well documented that zinc is an important mineral associated with growth and 
development in children.61 A review of research done on zinc composition during the first year 
of lactation concluded that milk concentrations vary between individuals and fall sharply in the 
first weeks of lactation, followed by a more gradual decline throughout the first year.62 Four 
semi-longitudinal studies47,49,51,52 into the second year of lactation describe a similar, time-
dependent decline in zinc concentrations, with steep declines ranging from 35% to 50% between 
1 month and 6 months postpartum, followed by more gradual declines thereafter. Zinc 
concentrations in the second year were observed to be 56% to 71% lower than concentrations in 
the first month of lactation.46,47,52 A small cross-sectional analysis involving 33 women from the 
Ivory Coast suggested that zinc concentrations were similar at 12 months and 18 months 
postpartum.46 Weaknesses of this study include the small sample size and the cross-sectional 
design that could mask the effects of inter-individual differences. A weaning effect was observed 
in 2 extended lactation studies where zinc concentrations fell with a decline in total daily milk 
volume49 and total number of feedings.51 Similar weaning effects on zinc concentration have 
been reported in another study where weaning occurred before 1 year postpartum.57 
 
Calcium. A review of research regarding calcium in human milk shows significant variation by 
geography, with few variables, besides adolescent motherhood and medical conditions, 
consistently impacting these variations.63 Five studies47,49,51,53,55 done in the second year of 
lactation reported a decline in calcium concentrations compared to levels during earlier lactation. 
A cross-sectional study of Gambian mothers showed a decline in calcium concentration, 
stabilizing at 9 to 12 months postpartum, while in British mothers, where diets were higher in 
calcium and breast milk concentrations were higher to start with, calcium levels continued to fall 
into the second year, with both groups reaching approximately 175 mg/L at 25 
months.53 Another cross-sectional study of 84 women found that the calcium concentration of 
milk in the second year of lactation was 27% lower than concentrations at 3 months 
postpartum.55 A semi-longitudinal study of 38 women reported a 23% decline in the first 18 
months,47 while another semi-longitudinal study of 40 mothers from the United States described 
a 24% decline between month 7 and month 22.51 A semi-longitudinal study of 46 Gambian 
mothers described calcium concentrations as unchanged, but their data conflicted with this 
assessment, showing trends toward lower mean calcium levels in milk samples collected 12 to 20 
months postpartum (209 ± 36 mg/L) compared to those collected 4 to 6 months postpartum (248 
± 37 mg/L), with a significant decrease associated with weaning (160 ± 37 mg/L), when milk 
volumes fell below 300 mL/day.49 Other studies that initiated weaning before 1 year postpartum 
suggest that calcium concentration is not affected by weaning.57,58 
 
Iron and copper. Iron and copper were analyzed in 3 extended lactation studies46,47,49 and 
showed similar patterns of change. Two studies described iron and copper levels declining 
during the first few months of lactation, with concentrations then stabilizing through 20 or more 
months postpartum.46,47 Observed iron concentration declines ranged from 20% to 25%, while 
copper concentration declines were reported as 35% to 70%. A semi-longitudinal study of 46 
Gambian women reported stable copper concentrations between 7 and 20 months, but iron 
concentrations showed a significant increase in the second year of lactation compared to levels at 
4 to 6 months.49 This rise in iron concentrations in the second year may be explained by a 
weaning effect, which was observed in 2 studies.49,57 There were no reported effects of weaning 
on copper concentrations. 
 
Immunoprotective Changes 
 
Immunoproteins. Only 2 studies48,50 examined the change in lactoferrin, lysozyme, and sIgA in 
the second year of lactation, indicating that this is an important area for future research. A semi-
longitudinal study of 152 Gambian women found that lactoferrin and sIgA levels declined 
approximately 25% in the first months postpartum and then remained stable up to 26 
months.50 Lysozyme levels in this study rose substantially over the course of lactation, with a 
220% increase at 15 to 18 months compared to concentrations at 0 to 3 months. Similarly, a 
cross-sectional study of 15 mothers showed that the concentration of sIgA, lactoferrin, and 
lysozyme remained stable between 12 and 24 months postpartum.48 While immunoprotein levels 
during the first year of lactation were not reported in this study, an earlier study by the same 
authors reported a significant increase in lysozyme levels at 6 months compared to early lactation 
levels.64 The effects of weaning on these proteins were reported in a small study where weaning 
began before 1 year postpartum. Concentrations remained stable, or even rose in some subjects, 
with the sIgA antibody titers to Escherichia coli increasing 4-fold.65 
 
Human milk oligosaccharides. No studies were found that looked at HMO concentrations 
during the second year of lactation. Given the growing evidence of the important 
immunoprotective and trophic roles that HMOs play in the developing neonate, this is an 
important area for future research. A longitudinal study that looked at HMO changes from week 
1 to week 49 postpartum showed that concentrations decreased by more than half, while the 
profile changed, with a decrease in 2’-fucosyllactose and an increase in 3’-fucosyllactose.66 This 
study also showed that there were large inter-individual variations in oligosaccharide quantities 
and profiles. As HMOs are the third most abundant ingredient in human milk and present only in 
trace amounts in bovine-based formula, this represents an important area for future research. 
 
Discussion 
 
Human milk is a dynamic fluid that changes significantly in its composition at the onset of 
lactation and then again during the late-weaning phase, when volumes drop below 300 to 400 
mL/day and the mammary gland goes through changes in secretory function.51 Understanding 
the changes in human milk composition throughout the duration of lactation is important for 
defining appropriate policies for donor milk banking. This review exposes a need for research 
related to the compositional changes in human milk at 1 year of lactation and beyond. Allowing 
mothers to donate milk beyond 1 year postpartum could increase the amount of milk available 
for fragile infants. However, while preterm and VLBW infants are the main recipients, donor 
milk is prophylactic against diseases for term infants and older children18 as well as adults.67 If it 
is shown that milk from mothers who are greater than 1 year postpartum has less nutritive and 
bioactive factors, milk from extended lactation could potentially be used for recipients other than 
preterm and VLBW infants if the milk banks have the resources to do so. It is also important to 
consider the immunoprotective capacity of donor milk beyond 1 year compared to the 
immunoprotective capacity of infant formula—the alternative when freezers are empty at donor 
milk banks—when making decisions about the value of accepting donations into the second year 
of lactation. 
 
Limitations of this review include the fact that 5 of the 12 studies were conducted in rural 
communities where suboptimal maternal nutrition may have had an effect on results; there was a 
wide variety of milk collection protocols that may have influenced the composition of the 
samples analyzed; and the sample sizes of the studies were relatively small, which reflects the 
limited population of women who continued to breastfeed into the second year of their child’s 
life. Additionally, because of the inter-individual variations in human milk that have been 
described,44,47,68 studies that used cross-sectional designs may mask time-dependent trends in the 
population. Finally, the majority of studies were conducted 20 to 40 years ago, and more refined 
analytical techniques may lead to different conclusions today. 
 
The body of existing research regarding human milk composition in the second year of lactation 
describes stable concentrations of several nutritive and immunoprotective components including 
protein, lactose, iron, copper, lactoferrin, and sIgA while milk volumes remain above 300 to 400 
mL/day. Concentrations of the antimicrobial protein lysozyme appear to increase into the second 
year of lactation. There is conclusive evidence that zinc and calcium levels continue to decline in 
the second year of lactation, with zinc levels showing the sharpest decline from early lactation 
levels. It has been proposed that zinc is actively transported in milk bound to a specific ligand, 
which is likely to be the milk proteins.69 As the mammary gland goes through involution during 
the weaning process, the mechanism of zinc secretion into human milk by binding to a ligand 
may decrease and zinc may increasingly be secreted into milk through the paracellular 
pathway.51 Calcium may decrease during extended lactation due to the increase in casein levels 
in milk during weaning, which may bind more calcium and decrease the more bioavailable 
ionized calcium.51 
 
While calcium and zinc concentrations decline in the second year of lactation, these minerals are 
more bioavailable in human milk than in bovine milk-based infant formulas. Calcium has a 
tendency to bind to casein, and because bovine milk is predominately casein, a substantial 
amount of the calcium is bound and less available for absorption.70 Human milk contains less 
casein and more whey proteins, leaving more calcium available for absorption in the ionized 
form.71 Zinc is more bioavailable in human milk than in bovine milk-based infant formulas 
because in human milk it is bound to the highly digestible proteins that may facilitate 
absorption.69 
 
The immunoprotective compounds reviewed in this study are unique features in human milk that 
contribute to its superior nature over bovine-based infant formulas. Immunoprotective features 
are especially critical for the preterm infant with an immature GI tract and immune system. 
Evidence of stable or rising immunoprotein levels during extended lactation provides an 
argument for allowing nonweaning mothers to donate milk during the second year postpartum. 
The components that appear to decline in the second year of lactation are minerals that can be 
added as supplements to an infant diet, while the immunoprotective compounds in human milk 
cannot be replicated. 
 
As new pasteurization techniques are discovered that preserve a greater percentage of the 
bioactive compounds in human milk, this will further differentiate the quality of donor human 
milk over bovine-based infant formula. New tools to study the proteome of human milk will also 
shape future discoveries in human milk by providing a deeper look into milk composition. For 
example, a proteome study out of the Netherlands showed that of the 268 proteins identified in 
human milk, 121 of these proteins (45%) were not found in bovine milk.36 
 
Recommendations 
 
Conflicting findings exist regarding the fat concentration of human milk; therefore, more 
research is needed in this area, with special considerations to collection protocols, given the 
varying nature of fat composition in human milk. Future research should also differentiate 
between weaning and nonweaning conditions, as many compounds in human milk are known to 
be impacted by the weaning process. Additional research into immunoprotein levels during 
extended lactation is warranted to validate the findings of the limited number of existing studies. 
More research is needed on HMOs, as there is currently no information on HMO concentrations 
and profiles during the second year of lactation. Other areas of future research should include 
examining whether infants would benefit from consuming milk donated later than 1 year 
postpartum rather than bovine-based infant formula due to the higher bioavailability of the 
minerals in human milk, despite the decline in mineral concentrations. Research into the 
composition of donor milk in Brazil, where there are no lactation-duration-based exclusions, 
would also provide insight into how extended-lactation donors potentially impact the quality of 
the donor milk supplied by their milk bank network. 
 
In 2011, The Surgeon General’s Call to Action to Support Breastfeeding was released by the US 
Department of Health and Human Services.72 The Call to Action describes ways in which people 
can participate in supporting the breastfeeding relationship between each mother and baby dyad. 
Action point 12 is to “identify and address obstacles to greater availability of safe banked donor 
milk for fragile infants.” Allowing mothers to donate milk beyond 1 year postpartum could 
increase the supply of donor milk in the United States and other countries where lactation-
duration-based exclusions are practiced, allowing greater access to donor milk for fragile infants. 
More research is needed to determine if this is a nutritionally safe and feasible option for 
increasing access to donor milk. 
 
Declaration of Conflicting Interests 
 
The authors declared no potential conflicts of interest with respect to the research, authorship, 
and/or publication of this article. 
 
Funding 
 
The authors received no financial support for the research, authorship, and/or publication of this 
article. 
 
References 
 
1. American Academy of Pediatrics . Policy statement: Breastfeeding and the use of human 
milk. Pediatrics. 2012;129(3):e827-e841. 
 
2. Horta, BL, Bahl, R, Martines, JC, Victora, CG. Evidence on the Long Term Effects of 
Breastfeeding. Geneva, Switzerland: World Health Organization; 2007. 
http://whqlibdoc.who.int/publications/2007/9789241595230_eng.pdf. Accessed November 11, 
2012. 
 
3. Belderbos, ME, Houben, ML, van Bleek, GM. Breastfeeding modulates neonatal innate 
immune responses: a prospective birth cohort study. Pediatr Allergy Immunol. 2012;23(1):65-74. 
 
4. Sullivan, S, Schanler, RJ, Kim, JH. An exclusively human milk-based diet is associated 
with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based 
products. J Pediatr. 2010;156(4):562-567. 
 
5. Sisk, PM, Lovelady, CA, Dillard, RG, Gruber, KJ, O’Shea, TM. Early human milk 
feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight 
infants. J Perinatol. 2007;27(7):428-433. 
 
6. Meinzen-Derr, J, Poindexter, B, Wrage, L. Role of human milk in extremely low birth 
weight infants’ risk of necrotizing enterocolitis or death. J Perinatol. 2009;29(1):57-62. 
 
7. Quigley, M, Henderson, G, Anthony, MY, McGuire, W. Formula milk versus donor 
breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev. 
2007;(4):CD002971. doi:10.1002/14651858.CD002971.pub2. 
 
8. Catassi, C, Bonucci, A, Coppa, GV, Carlucci, A, Giorgi, PL. Intestinal permeability 
changes during the first month: effect of natural versus artificial feeding. J Pediatr Gastroenterol 
Nutr. 1995;21(4):383-386. 
 
9. Shulman, RJ, Schanler, RJ, Lau, C. Early feeding, feeding tolerance, and lactase activity 
in preterm infants. J Pediatr. 1998;133(5):645-649. 
 
10. Groër, M, Walker, WA. What is the role of preterm breast milk supplementation in the 
host defenses of preterm infants? Science vs. fiction. Adv Pediatr. 1996;43:335-358. 
 
11. Schanler, RJ, Atkinson, SA. Effects of nutrients in human milk on the recipient 
premature infant. J Mammary Gland Biol Neoplasia. 1999;4(3):297-307. 
 
12. Narayanan, I, Prakash, K, Bala, S, Verma, RK, Gujral, VV. Partial supplementation with 
expressed breast-milk for prevention of infection in low-birth-weight infants. Lancet. 
1980;2(8194):561-563. 
 
13. Patel, AL, Johnson, TJ, Engstrom, JL. Impact of early human milk on sepsis and health-
care costs in very low birth weight infants [published online January 31, 2013]. J Perinatol. 
doi:10.1038/jp.2013.2. 
 
14. Goldblum, RM, Schanler, RJ, Garza, C, Goldman, AS. Human milk feeding enhances the 
urinary excretion of immunologic factors in low birth weight infants. Pediatr Res. 1989;25(2): 
184-188. 
 
15. Arnold, LD. Use of donor milk in the treatment of metabolic disorders: glycolytic 
pathway defects. J Hum Lact. 1995;11(1):51-53. 
 
16. Anderson, A, Arnold, LD. Use of donor breastmilk in the nutrition management of 
chronic renal failure: three case histories. J Hum Lact. 1993;9(4):263-264. 
 
17. Arnold, LD. Use of donor human milk in the management of failure to thrive: case 
histories. J Hum Lact. 1995;11(2): 137-140. 
 
18. Tully, MR. Recipient prioritization and use of human milk in the hospital setting. J Hum 
Lact. 2002;18(4):393-396. 
 
19. Villanueva, T. First human breast milk bank opens in Africa. BMJ. 2011;343:d5179. 
 
20. Purdy, C. Human milk banks: Canada rebirth of milk depositories could save babies, 
health-care dollars. Huffington Post Canada. http://www.huffingtonpost.ca/2012/10/22/human-
milk-banks-canada_n_1999496.html. Published October 22, 2012. Accessed March 19, 2013. 
 
21. Shinde, S. Pune gets its first human milk bank. The Times of India. 
http://articles.timesofindia.indiatimes.com/2011-06-24/pune/29698935_1_human-milk-milk-
bank-heat-treatment. Published June 24, 2011. Accessed November 16, 2012. 
 
22. Mercy Health Breastmilk Bank opening . Mercy Health Breastmilk Bank Website. 
http://www.mercyhealthbreastmilkbank.com.au/#/about-us/latest-updates. Accessed November 
15, 2012. 
 
23. Johnson, C. , Bay area milk bank facing increased demand. ABC KGO-TV San 
Francisco. 
http://abclocal.go.com/kgo/story?section=news/health&id=8807295&utm_source=buffer&buffer
_share=e2ab6. Published September 11, 2012. Accessed October 22, 2012. 
 
24. Mother’s Milk Bank of Iowa submits urgent call for donations . Iowa Breastfeeding 
Coalition Website. http://iabreastfeeding.org/2011/10/mothers-milk-bank-of-iowa-submits-
urgent-call-for-donations/. Published October 14, 2011. Accessed October 22, 2012. 
 
25. World Health Organization . Born too soon: the global action report on preterm births. 
Geneva, Switzerland: World Health Organization. 
http://www.who.int/pmnch/media/news/2012/201204_borntoosoon-report.pdf. Published 2012. 
Accessed November 5, 2012. 
 
26. A network of Brazilian banks of human milk . Brazil Ministry of Health Website. 
http://www.redeblh.fiocruz.br/cgi/cgilua.exe/sys/start.htm?tpl=home. Accessed October 23, 
2012. 
 
27. Human Milk Bank Association of North America Website . https://www.hmbana.org/. 
Accessed October 23, 2012. 
 
28. Canadian Institute for Health Information. Highlights of 2010-2011 selected indicators 
describing the birthing process in Canada . 
https://secure.cihi.ca/free_products/Childbirth_Highlights_2010-11_EN.pdf. Published March 
2012. Accessed November 5, 2012. 
 
29. PREM bank FAQs for donors . Government of Western Australia Department of Health 
Website. http://www.kemh.health.wa.gov.au/services/PREM_Bank/FAQ.htm. Accessed 
November 15, 2012. 
 
30. Milk banks . Brazil government Website. 
http://www.brasil.gov.br/sobre/health/programs-and-campaigns/milk-banks-
1/br_video?set_language=en. Accessed November 2, 2012. 
 
31. Donation breast milk: a generous gesture and simple . Lactariums de France Website. 
http://sdp.perinat-france.org/ADLF/don_lait_maternel_donner_adlf.php. Accessed November 2, 
2012. 
 
32. The donation of human milk: a simple but important gesture . Associazione Italiana 
Banche del Latte Umano Donato Website. http://aiblud.wordpress.com/donare-il-latte/. Accessed 
November 2, 2012. 
 
33. How does one go about donating breastmilk? Milk Matters Website. 
http://www.milkmatters.org/donatemilk/process.html. Accessed November 2, 2012. 
 
34. Milk donor FAQs . United Kingdom Association for Milk Banking Website. 
http://www.ukamb.org/donating-milk/milk-donor-faqs/. Accessed November 2, 2012. 
 
35. Hamosh, M. Bioactive factors in human milk. Pediatr Clin North Am. 2001;48(1):69-86. 
 
36. Hettinga, K, van Valenberg, H, de Vries, S. The host defense proteome of human and 
bovine milk. PLoS One. 2011;6(4):e19433. 
 
37. Kunz, C, Rudloff, S, Baier, W, Klein, N, Strobel, S. Oligosaccharides in human milk: 
structural, functional, and metabolic aspects. Annu Rev Nutr. 2000;20:699-722. 
 
38. Hanson, LA, Korotkova, M, Telemo, E. Human milk: its components and their 
immunobiological functions. In: Mestecky, J , ed. Mucosal Immunology. 3rd ed. Waltham, MA: 
Academic Press; 2004:1795-1827. 
 
39. Mantis, NJ, Forbes, SJ. Secretory IgA: arresting microbial pathogens at epithelial 
borders. Immunol Invest. 2010;39(4-5):383-406. 
 
40. Zivkovic, AM, German, JB, Lebrilla, CB, Mills, DA. Human milk glycobiome and its 
impact on the infant gastrointestinal microbiota. P Natl Acad Sci USA. 2011;108(suppl 1):1-6. 
 
41. Bode, L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology. 
2012;22(9):1147-1162. 
 
42. Ewaschuk, JB, Unger, S, Harvey, S, O’Connor, DL, Field, CJ. Effect of pasteurization on 
immune components of milk: implications for feeding preterm infants. Appl Physiol Nutr Metab. 
2011;36(2):175-182. 
 
43. Bertino, E, Coppa, GV, Giuliani, F. Effects of Holder pasteurization on human milk 
oligosaccharides. Int J Immunopathol Pharmacol. 2008;21(2):381-385. 
 
44. Allen, JC, Keller, RP, Archer, P, Neville, MC. Studies in human lactation: milk 
composition and daily secretion rates of macronutrients in the first year of lactation. Am J Clin 
Nutr. 1991;54(1):69-80. 
 
45. Underwood, BA, Hepner, R, Abdullah, H. Protein, lipid, and fatty acids of human milk 
from Pakistani women during prolonged periods of lactation. Am J Clin Nutr. 1970;23(4):400-
407. 
 
46. Lauber, E, Reinhardt, M. Studies on the quality of breast milk during 23 months of 
lactation in a rural community of the Ivory Coast. Am J Clin Nutr. 1979;32(5):1159-1173. 
 
47. Vaughan, LA, Weber, CW, Kemberling, SR. Longitudinal changes in the mineral content 
of human milk. Am J Clin Nutr. 1979;32(11):2301-2306. 
 
48. Goldman, AS, Goldblum, RM, Garza, C. Immunologic components in human milk 
during the second year of lactation. Acta Paediatr Scand. 1983;72(3):461-462. 
 
49. Dewey, KG, Finley, DA, Lönnerdal, B. Breast milk volume and composition during late 
lactation (7-20 months). J Pediatr Gastroenterol Nutr. 1984;3(5):713-720. 
 
50. Prentice, A, Prentice, AM, Cole, TJ, Paul, AA, Whitehead, RG. Breast-milk 
antimicrobial factors of rural Gambian mothers. I. Influence of stage of lactation and maternal 
plane of nutrition. Acta Paediatr Scand. 1984;73(6):796-802. 
 
51. Karra, MV, Udipi, SA, Kirksey, A, Roepke, JL. Changes in specific nutrients in breast 
milk during extended lactation. Am J Clin Nutr. 1986;43(4):495-503. 
 
52. Bates, CJ, Tsuchiya, H. Zinc in breast milk during prolonged lactation: comparison 
between the UK and the Gambia. Eur J Clin Nutr. 1990;44(1):61-69. 
 
53. Laskey, MA, Prentice, A, Shaw, J. Breast-milk calcium concentrations during prolonged 
lactation in British and rural Gambian mothers. Acta Paediatr Scand. 1990;79(5):507-512. 
 
54. Mandel, D, Lubetzky, R, Dollberg, S, Barak, S, Mimouni, FB. Fat and energy contents of 
expressed human breast milk in prolonged lactation. Pediatrics. 2005;116(3):e432-e435. 
 
55. Shehadeh, N, Aslih, N, Shihab, S. Human milk beyond one year post-partum: lower 
content of protein, calcium, and saturated very long-chain fatty acids. J Pediatr. 
2006;148(1):122-124. 
 
56. Lubetzky, R, Zaidenberg-Israeli, G, Mimouni, FB. Human milk fatty acids profile 
changes during prolonged lactation: a cross-sectional study. Isr Med Assoc J. 2012;14(1):7-10. 
 
57. Garza, C, Johnson, CA, Smith, EO, Nichols, BL. Changes in the nutrient composition of 
human milk during gradual weaning. Am J Clin Nutr. 1983;37(1):61-65. 
 
58. Neville, MC, Allen, JC, Archer, PC. Studies in human lactation: milk volume and 
nutrient composition during weaning and lactogenesis. Am J Clin Nutr. 1991;54(1):81-92. 
 
59. Gunther, M, Stanier, JE. Diurnal variation in the fat content of breast-milk. Lancet. 
1949;2(6571):235-237. 
 
60. Miller, EM, Aiello, MO, Fujita, M. Field and laboratory methods in human milk research. 
Am J Hum Biol. 2013;25(1):1-11. 
 
61. Salgueiro, MJ, Zubillaga, MB, Lysionek, AE. The role of zinc in the growth and 
development of children. Nutrition. 2002;18(6):510-519. 
 
62. Dorea, J. Zinc in human milk. Nutr Res. 2000;20(11): 1645-1687. 
 
63. Dorea, J. Calcium and phosphorus in human milk. Nutr Res. 1999;19(5):709-739. 
 
64. Goldman, AS, Garza, C, Nichols, BL, Goldblum, RM. Immunologic factors in human 
milk during the first year of lactation. J Pediatr. 1982;100(4):563-567. 
 
65. Goldman, AS, Goldblum, RM, Garza, C, Nichols, BL, Smith, EO. Immunologic 
components in human milk during weaning. Acta Paediatr Scand. 1983;72(1):133-134. 
 
66. Chaturvedi, P, Warren, CD, Altaye, M. Fucosylated human milk oligosaccharides vary 
between individuals and over the course of lactation. Glycobiology. 2001;11(5):365-372. 
 
67. Merhav, HJ, Wright, HI, Mieles, LA, van Thiel, DH. Treatment of IgA deficiency in liver 
transplant recipients with human breast milk. Transpl Int. 1995;8(4):327-329. 
 
68. Góes, HC, Torres, AG, Donangelo, CM, Trugo, NM. Nutrient composition of banked 
human milk in Brazil and influence of processing on zinc distribution in milk fractions. 
Nutrition. 2002;18(7-8):590-594. 
 
69. DiSilvestro, RA, Cousins, RJ. Physiological ligands for copper and zinc. Annu Rev Nutr. 
1983;3:261-288. 
 
70. Flynn, A. Minerals and trace elements in milk. Adv Food Nutr Res. 1992;36:209-252. 
 
71. Shen, L, Robberecht, H, van Dael, P, Deelstra, H. Estimation of the bioavailability of 
zinc and calcium from human, cow’s, goat, and sheep milk by an in vitro method. Biol Trace 
Elem Res. 1995;49(2-3):107-118. 
 
72. US Department of Health and Human Services . The Surgeon General’s Call to Action to 
Support Breastfeeding. Washington, DC: US Dept of Health and Human Services, Office of the 
Surgeon General; 2011. 
 
73. For our current donors . WakeMed Mothers’ Milk Bank Website. 
http://www.wakemed.org/body.cfm?id=1524. Accessed March 27, 2013. 
 
74. Donate milk . Calgary Mothers’ Milk Bank Website. 
http://www.calgarymothersmilkbank.ca/donate_milk.html. Accessed March 27, 2013. 
 
75. Donating milk . BC Women’s Milk Bank Website. 
http://bcwomensmilkbank.ca/donating-milk/. Accessed March 27, 2013. 
 
76. Did you know? Indiana Mothers’ Milk Bank Website . http://www.immilkbank.org/faqs/. 
Accessed March 27, 2013. 
 
77. Becoming a milk donor . Mothers’ Milk Bank of New England Website. 
http://www.milkbankne.org/donate.shtml. Accessed March 27, 2013. 
 
78. Donate milk . Mothers’ Milk Bank of Austin Website. http://www.milkbank.org/donate-
milk/. Accessed March 27, 2013. 
